Cancer News

May Is National Skin Cancer Detection and Prevention Month (05/18/2018)

Sun Valley, ID —OMNI Health  (OMNI) announces the launch of skin cancer programs for national skin cancer detection and prevention month. As the month of May brings skin cancer into focus, it’s time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated …

Continue reading "May Is National Skin Cancer Detection and Prevention Month"

TafinlarĀ® + MekinistĀ® Demonstrates Long Term Survival Benefit for BRAF Mutation-Positive Metastatic Melanoma (04/05/2018)

CancerConnect News: Metastatic melanoma patients with the BRAF V600 mutation treated with the combination of Tafinlar® (dabrafenib) + Mekinist® (trametinib) can experience long term cancer free survival according to results presented at the 53rdAnnual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago.1 About Melanoma  Metastatic melanoma refers to skin cancer that has spread from …

Continue reading "Tafinlar® + Mekinist® Demonstrates Long Term Survival Benefit for BRAF Mutation-Positive Metastatic Melanoma"

PD-1 Antibody Cemiplimab Appears Promising for Treatment of Squamous Cell Carcinoma of the Skin (02/02/2018)

Cemiplimab an investigational human antibody targeting PD-1 (programmed cell death protein 1), is yet another “checkpoint inhibitor” that was evaluated in 82 patients with advanced cutaneous squamous cell carcinoma (CSCC).  Early trial results suggest that cemiplimab may represent a viable treatment option for individuals diagnosed with CSCC. About Cutaneous Squamous Cell Carcinoma (CSCC) CSCC is …

Continue reading "PD-1 Antibody Cemiplimab Appears Promising for Treatment of Squamous Cell Carcinoma of the Skin"

Start 2018 Right: Plan for Cancer Screening and Save Lives! (01/05/2018)

Screening guidelines should initiate conversations with your healthcare team.  Charles H Weaver MD, Editor CancerConnect CancerConnect News: The goal of cancer screening is to find disease at early stages in people who are otherwise asymptomatic—before it causes symptoms and when it may be more easily treatable.  Screening tests are not available for every type of …

Continue reading "Start 2018 Right: Plan for Cancer Screening and Save Lives!"

Skin Cancer Prevention Tips from the Skin Cancer Foundation (05/17/2017)

The development of skin cancer is certainly a risk for any individual, but particularly for those of us who spend time in the outdoors. As summer approaches it’s important to keep in mind that by taking certain steps to protect yourself from the sun, you can safely enjoy your time outside. The following recommendations from …

Continue reading "Skin Cancer Prevention Tips from the Skin Cancer Foundation"

Check It Out: May is Skin Cancer Awareness Month (05/01/2017)

Skin cancer is the most commonly diagnosed cancer in the United States. Although the majority of skin cancers fall under basal cell and squamous cell carcinomas (number of cases estimated to be around 5 million), most deaths are a result of melanoma which accounts for approximately 1% of cases. In 2016, the ACS estimates 76,380 …

Continue reading "Check It Out: May is Skin Cancer Awareness Month"

FDA Approves Bavencio as First Treatment for Merkel Cell Cancer (03/31/2017)

The U.S. Food and Drug Administration today granted accelerated approval to Bavencio (avelumab) for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma (MCC), including those who have not received prior chemotherapy. This is the first FDA-approved treatment for metastatic MCC. According to the National Cancer Institute, approximately …

Continue reading "FDA Approves Bavencio as First Treatment for Merkel Cell Cancer"

Promising Activity of Pembrolizumab in Merkel Cell Carcinoma (06/14/2016)

Treatment of 26 patients with advanced previously untreated Merkel cell carcinoma with Keytruda® (pembrolizumab) every three weeks resulted in an overall response rate of 56% suggesting this novel therapy could represent a new treatment option for these hard to treat cancers. Merkel cell carcinoma is a rare aggressive skin cancer with limited treatment options for … Continue reading "Promising Activity of Pembrolizumab in Merkel Cell Carcinoma"